Shore Capital reiterated their house stock rating on shares of Anpario (LON:ANP – Get Rating) in a report issued on Tuesday, MarketBeat reports.
Anpario Stock Performance
Shares of Anpario stock opened at GBX 207.50 ($2.58) on Tuesday. The firm has a market capitalization of £49.82 million, a P/E ratio of 1,383.33 and a beta of 0.73. Anpario has a 52 week low of GBX 177.70 ($2.21) and a 52 week high of GBX 611.50 ($7.61). The company has a quick ratio of 5.16, a current ratio of 6.71 and a debt-to-equity ratio of 0.13. The firm’s 50 day moving average is GBX 238.10 and its two-hundred day moving average is GBX 349.27.
Anpario Increases Dividend
The business also recently disclosed a dividend, which will be paid on Friday, July 28th. Shareholders of record on Thursday, July 13th will be paid a GBX 7.35 ($0.09) dividend. This represents a yield of 2.37%. The ex-dividend date is Thursday, July 13th. This is an increase from Anpario’s previous dividend of $3.15. Anpario’s dividend payout ratio is currently 6,666.67%.
Insider Buying and Selling at Anpario
About Anpario
Anpario plc, together with its subsidiaries, produces and distributes natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salgard, Salkil, Genex, and Optimax brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Salkil, Salgard, Oxigard, Moldgard, and Mastercube brands.
Featured Stories
- Airline ETFs: What They Are and How to Invest
- Williams-Sonoma Is The Retail Value Play, Here’s Why
- Ladder Corporation: Climbing Higher And Paying 9% Yield
- Microbot Medical spikes 150% on its Endovascular Surgical Robot
- PetMed Express: Charts Say This Could Be The Bottom
Receive News & Ratings for Anpario Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anpario and related companies with MarketBeat.com's FREE daily email newsletter.